Observational studyActa diabetologica2026
Dapagliflozin is associated with a reduction in left atrial volume index in type 2 diabetes mellitus without established cardiovascular disease.
Bilal Çakır et al.PubMed ↗Publisher ↗
No numbers read from the abstract.